Prostate Cancer - Results from #27580

Innovations in hormonal treatment for locally advanced and/or metastatic prostate cancer - Abstract June 29, 2011

Treating prostate cancer in elderly men: How does aging affect the outcome? - Abstract June 29, 2011

Intake of whole-grain products and risk of prostate cancer among men in the Danish Diet, Cancer and Health cohort study - Abstract June 29, 2011

Outcome after surgery for metastatic spinal cord compression in 54 patients with prostate cancer - Abstract June 29, 2011

Photodynamic diagnosis of positive margin during radical prostatectomy: Preliminary experience with 5-aminolevulinic acid - Abstract June 29, 2011

Shared decision making: Prostate cancer patients' appraisal of treatment alternatives and oncologists' eliciting and responding behavior, an explorative study - Abstract June 29, 2011

Use of implanted markers and interportal adjustment with real-time tracking radiotherapy system to reduce intrafraction prostate motion - Abstract June 29, 2011

Management of metastatic castration-resistant prostate cancer after first-line docetaxel - Abstract June 29, 2011

Prognostic significance of positive surgical margins after radical prostatectomy among pT2 and pT3a prostate cancer - Abstract June 29, 2011

Insulin-like growth factor pathway: A link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer? - Abstract June 29, 2011

Career opportunity: Chief Scientific Officer, Prostate Cancer Canada (PCC) June 29, 2011

Editor's Commentary - The change of PSA doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen deprivation June 29, 2011

The CAPRA-S score: A straightforward tool for improved prediction of outcomes after radical prostatectomy - Abstract June 28, 2011

Evolution of modern imaging and development of targeted prostatic biopsies for the diagnosis of prostate cancer - Abstract June 28, 2011

Cancer multitarget pharmacology in prostate tumors: Tyrosine kinase inhibitors and beyond - Abstract June 28, 2011

Three-year postoperative ultrasensitive prostate-specific antigen following open radical retropubic prostatectomy is a predictor for delayed biochemical recurrence - Abstract June 28, 2011

Development and validation of a utility weighting function for the patient-oriented prostate utility scale (PORPUS) - Abstract June 28, 2011

Treatment effects in the prostate including those associated with traditional and emerging therapies - Abstract June 28, 2011

Prostate volume has prognostic value only in pathologic T2 radical prostatectomy specimens - Abstract June 28, 2011

Association of short tandem repeat polymorphism in the promoter of prostate cancer antigen 3 gene with the risk of prostate cancer - Abstract June 28, 2011

Page 1380 of 1435